 LA JOLLA, Calif., Dec. 21, 2020 PRNewswire -- Avidity Biosciences, Inc. Nasdaq: RNA, a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates AOCsTM, today announced that it has been added to the Nasdaq... 